好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

In the kingdom of triphasic waves, white matter is the eminence grise
Epilepsy/Clinical Neurophysiology (EEG)
P4 - Poster Session 4 (5:30 PM-6:30 PM)
6-011
The objective of this study is to explore the role of white matter disease (WMD) in the generation of Triphasic Waves (TWs) when other common causes associated with these discharges are absent.
TWs, or generalized periodic discharges (GPDs) with triphasic morphology, have been associated with multiple conditions and associated with adverse outcomes.  WMD is found in a significant proportion of these cases but it is unclear if it is a major contributor to the generation of TWs.  

This is a retrospective case series performed at Johns Hopkins Bayview Medical Center from January 2016 to May 2018, which screened for patients with severe WMD, who had TWs on electroencephalography (EEG) without the presence of commonly cited provoking factors, including 1) hepatic disease; 2) severe uremia over baseline; 3) the drugs cefepime, ifosfamide, lithium, and baclofen; or 4) global hypoxic-ischemic injury.

Eight patients were identified. Out of this group, 100% had mild calcium derangement and 88% had infection (38% urinary tract infection [UTI], 25% respiratory infection, and 25% central nervous system [CNS] infection).

This is the first series to demonstrate convincingly the presence of TWs in patients with WMD in the absence of commonly cited risk factors. We hypothesize that WMD, combined with these less recognized and often mild risk factors, may be drivers of TW appearance. With a growing elderly population, the presence of white matter disease will increase, and treating physicians need to look beyond the common causes of TWs. The two lesser-recognized causes—white matter disease and metabolic or infectious abnormality—may account for the appearance of TWs.

Authors/Disclosures
Ivan Kotchetkov, MD (Memorial Sloan Kettering Cancer Center)
PRESENTER
No disclosure on file
Brin Freund, MD Dr. Freund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Freund has received research support from Mayo Clinic.
Peter W. Kaplan, MBBS, FRCP, FAAN (Johns Hopkins Bayview) Dr. Kaplan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for DNP Epiwatch. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for IFCN. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Kaplan has received publishing royalties from a publication relating to health care.